Strategic planning for bioanalytical
automation: managing growth successfully |
| |
Authors: | Julie J. Tomlinson |
| |
Affiliation: | . Department of Clinical Pharmacology, Glaxo Inc., Five Moore Drive, Research Triangle Park, North Carolina, USA, |
| |
Abstract: | Bioanalytical automation expanded at Glaxo Inc. from 1987 to1991 by cycling through periods of justification, planning,implementation, obstacle-jumping and success, which justifiedcontinued cycling. In 1990 it became evident that the technology andits growth needed to be planned and the resources had to bemanaged. A Strategic Plan was researched and prepared. The plandescribes the mission, values, goals and structure of the BioanalyticalAutomation Group and the most important requirements forachieving those planned goals, including: (1) Long-term managementcommitment; (2) Trained, dedicated personnel; (3) Qualityfacilities; (4) Teamwork; and (5) Investment in automationcompatibleequipment. The strategic plan has been in effect for overa year; current status, history, and the future are discussed in this article. |
| |
Keywords: | |
|
|